DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Dhir M, Zenati MS, Hamad A. et al.
FOLFIRINOX versus gemcitabine/nab-paclitaxel for neoadjuvant treatment of resectable and borderline resectable pancreatic head adenocarcinoma.
Ann Surg Oncol 2018;
25 (07) 1896-1903
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.